SEC Form 4 · accession 0001213900-26-066393
Turn Therapeutics Inc. · TTRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur F Golden
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 5:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002023016
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $5.75 | Jun 4, 2026 | A | 89,584 | A | — | Jun 4, 2036 | Common Stock | 89,584 | 89,584 | D |
Explanation of responses
- F1The option will vest in twelve (12) equal monthly installments, on the last day of each calendar month, commencing on June 30, 2026, subject to the Reporting Person's continued employment and the terms and conditions of the applicable option award and the Issuer's 2025 Omnibus Incentive Plan.